Cargando…
Radiotherapy, PARP Inhibition, and Immune-Checkpoint Blockade: A Triad to Overcome the Double-Edged Effects of Each Single Player
SIMPLE SUMMARY: While radiotherapy remains a key therapy for many cancers, in recent years, DNA repair inhibitors, particularly PARP inhibitors, and immunotherapy, specifically immune-checkpoint inhibitors, have progressively shown great therapeutic potential in several experimental and clinical set...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954050/ https://www.ncbi.nlm.nih.gov/pubmed/36831435 http://dx.doi.org/10.3390/cancers15041093 |